苏州慧捷自动化科技
加入合集苏州慧捷自动化科技有限公司(简称慧捷科技),是先进制造自动化装备高科技企业,成立于2004年,专攻电子半导体、生物医药(+器械)的高效智能设备及生产线。
机械工业行业企业生物医药电子半导体SiP先进封装苏州慧捷自动化科技有限公司慧捷科技工厂自动化智能装备精准定制研发制造专业服务商,擅长于产品工艺分析与机构设计优化匹配、高速运动控制、机器视觉二次开发、测试通讯和数据实时处理。
相关导航
westvacbiopharmaisfoundedbyacademicianweiyuquanfromwestchinahospitalofsichuanuniversity,togetherwithscientistsfromstatekeylaboratoryofbiotherapy(sklb).itsheadquarterislocatedintheinternationalbio-town,chengdu.theceoofwestvacbiopharmaisprof.weiyuquan,whoistheacademicianofchineseacademyofsciencesaswellasthedirectorofstatekeylaboratoryofbiotherapy.westvaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.ithasattachedgreatimportanceintheresearchanddevelopment(r&d)ofcovid-vaccineespeciallyandbuildingacovid-vaccineproductionplatform.statekeylaboratoryofbiotherapy(sklb)wasestablishedbytheministryofsciencesandtechnologyofchinainandbecameoneofthenationalr&dplatformsfornoveldrugsfoundedbytheministriesofsciencesandtechnologyaswellasthatofhealthofchinain.itisalsosupportedbynationalcollaborativeinnovationprogramandhasbecomethenationalcollaborativeinnovationcenterforbiotherapysince.westchinahospitalofsichuanuniversity,foundedin,isthenationalcenterfordiagnosisandtreatmentofsevereandcriticaldiseasesinwesternchina.itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.relyingonthemedicalresourcesofstatekeylaboratoryofbiotherapyandwestchinamedicalcenter,westvachasadoptedrecombinantproteinmethodologytodevelopthecovid-vaccine.becauseofthesafetyoftheproteinvaccine,itisalsotheonlycovid-vaccineapprovedfortheuseinchildrenoveryearsoldinchina.thevaccinewasapprovedbythenationalmedicalproductsadministrationforclinicaltrialsonaugust,.phasei/iiclinicaltrialshavebeencompleted,andphaseiiiclinicaltrialsarebeingcarriedoutinnepal,kenya,japanandothercountries.thevaccinetargetsthespikeproteinbindingdomain(s-rbd)ofsars-cov-,producingneutralizingantibodiestoblockcovid-infectionofhumancells.theresultwaspublishedonnature,theworld’sfamousscientificjournalonjulyth,.ithasalsobeenthefirstpaperofcovidvaccinepublishedbynaturesincethepandemicoutbreak.thes-rbdgeneofthecovid-virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.suchtechnologyiseasytobemass-producedandbroughttothemarket.westvacbiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.
山东省医药工业设计院有限公司(以下简称“山东省医工设计院”)成立于年,坐落在美丽的泉城——济南,是国家医药行业的骨干设计单位,持有建设部核准颁发的化工石化医药行业甲级资质,建筑行业(建筑工程)乙级资质,原国家质监总局颁发的gc级、gc级压力管道设计资质,获iso:国际质量体系认证,是国家工程咨询资信评价甲级单位,主要从事化学合成药、中药、医药制剂、医药包装材料、医药中间体、医疗器械、医药物流、药用辅料、生物医药、化妆品、保健食品等领域的咨询和设计服务,先后荣获国家、省部级优秀工程设计、咨询成果奖百余项,拥有较高知名度,是国内最资深和全面的医药工程专业服务商之一,并分别在上海和广州设立分公司。
